Anne-Sophie R. Stroes, Laura Draijer, Hedy A. van Oers, Malika Chegary, Felix Kreier, Erim van Os, Joery Goede, Venje Boonstra, Ilse Westerbeek, Saskia Bouma, D. Meeike Kusters, Roosje Roelants, Ulrich Beuers, Adriaan G. Holleboom, Marc A. Benninga, Bart G.P. Koot
{"title":"Children’s experience of screening and evaluation for MASLD in overweight and obesity","authors":"Anne-Sophie R. Stroes, Laura Draijer, Hedy A. van Oers, Malika Chegary, Felix Kreier, Erim van Os, Joery Goede, Venje Boonstra, Ilse Westerbeek, Saskia Bouma, D. Meeike Kusters, Roosje Roelants, Ulrich Beuers, Adriaan G. Holleboom, Marc A. Benninga, Bart G.P. Koot","doi":"10.1016/j.orcp.2025.12.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>This study evaluates self-reported discomfort in children undergoing screening and evaluation for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) that includes blood sampling and vibration-controlled transient elastography (VCTE) or shear-wave elastography (SWE).</div></div><div><h3>Methods</h3><div>In this cross-sectional multicenter cohort study, children with overweight or obesity, referred for MASLD evaluation after elevated ALT, were included. Children subsequently underwent anthropometric measurements, blood sampling, VCTE, and SWE during an outpatient visit. Discomfort was assessed using the validated “Discomfort in Research with Children” (DISCO-RC) questionnaire on a 5-point Likert scale.</div></div><div><h3>Results</h3><div>118 children (mean age 13 years) were included. Discomfort related to MASLD screening was low, with median domain scores of 1–2 before the MASLD evaluation visit and 1 after. Prior to the visit, 76–82 % reported “no” to “slight” discomfort (score 1–2) across domains; during the visit, this was 91–95 %. Median procedural discomfort per domain was 1 for both VCTE and SWE, though cumulative discomfort (6 domains) was greater for VCTE than SWE (8 [IQR 6,9] versus 7 [IQR 6,8] <em>p</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>Screening and subsequent evaluation for MASLD, including VCTE or SWE for liver fibrosis assessment, is associated with minimal discomfort and is highly acceptable to children, supporting this screening strategy in pediatric clinical practice.</div></div>","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"20 1","pages":"Pages 76-79"},"PeriodicalIF":2.4000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity research & clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871403X25001553","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
This study evaluates self-reported discomfort in children undergoing screening and evaluation for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) that includes blood sampling and vibration-controlled transient elastography (VCTE) or shear-wave elastography (SWE).
Methods
In this cross-sectional multicenter cohort study, children with overweight or obesity, referred for MASLD evaluation after elevated ALT, were included. Children subsequently underwent anthropometric measurements, blood sampling, VCTE, and SWE during an outpatient visit. Discomfort was assessed using the validated “Discomfort in Research with Children” (DISCO-RC) questionnaire on a 5-point Likert scale.
Results
118 children (mean age 13 years) were included. Discomfort related to MASLD screening was low, with median domain scores of 1–2 before the MASLD evaluation visit and 1 after. Prior to the visit, 76–82 % reported “no” to “slight” discomfort (score 1–2) across domains; during the visit, this was 91–95 %. Median procedural discomfort per domain was 1 for both VCTE and SWE, though cumulative discomfort (6 domains) was greater for VCTE than SWE (8 [IQR 6,9] versus 7 [IQR 6,8] p < 0.001).
Conclusions
Screening and subsequent evaluation for MASLD, including VCTE or SWE for liver fibrosis assessment, is associated with minimal discomfort and is highly acceptable to children, supporting this screening strategy in pediatric clinical practice.
期刊介绍:
The aim of Obesity Research & Clinical Practice (ORCP) is to publish high quality clinical and basic research relating to the epidemiology, mechanism, complications and treatment of obesity and the complication of obesity. Studies relating to the Asia Oceania region are particularly welcome, given the increasing burden of obesity in Asia Pacific, compounded by specific regional population-based and genetic issues, and the devastating personal and economic consequences. The journal aims to expose health care practitioners, clinical researchers, basic scientists, epidemiologists, and public health officials in the region to all areas of obesity research and practice. In addition to original research the ORCP publishes reviews, patient reports, short communications, and letters to the editor (including comments on published papers). The proceedings and abstracts of the Annual Meeting of the Asia Oceania Association for the Study of Obesity is published as a supplement each year.